Valaris Ltd (VAL)

Nine analysts have assigned Valaris Limited (NYSE:VAL) a consensus recommendation of "Reduce," with one analyst issuing a sell rating and eight others recommending a hold. The average 12-month price target for the stock is $60.9375. Institutional investors have significantly increased their holdings in Valaris, and the company recently reported strong quarterly earnings, surpassing analyst estimates.

Valaris (VAL) recently reported strong Q2 earnings, with revenue 8% above expectations and EPS also exceeding forecasts, leading to a 12.3% stock increase since the report. Despite a significant year-to-date share price return of 70.66%, its current share price of US$89 suggests a 32.3% overvaluation based on a common narrative that pegs fair value at $67.27. However, Simply Wall St's DCF model indicates the stock is heavily undervalued, with a fair value of $658 per share, creating a wide discrepancy between valuation methods.

Valaris (VAL) recently reported strong Q2 earnings, with revenue 8% above analyst expectations and earnings per share exceeding forecasts, leading to a 12.3% stock increase. Despite a year-to-date share price return of 70.66%, its 90-day return shows a 12.03% decline. Analysts' fair value places the stock at $67.27, suggesting it's 32.3% overvalued, while a Discounted Cash Flow (DCF) model from Simply Wall St indicates it could be heavily undervalued at $658 per share.

Empowered Funds LLC significantly reduced its stake in Valaris Limited by 75.6% in the first quarter, selling 19,862 shares and retaining 6,399 shares. Despite this, other institutional investors, including Healthcare of Ontario Pension Plan Trust Fund, increased their positions, with institutions collectively owning 96.74% of Valaris shares. Valaris surpassed quarterly earnings expectations, reporting $0.72 EPS against a $0.31 consensus, though revenue saw a 12.4% year-over-year decline.

Valaris (VAL) recently reported weaker Q2 2026 results, with revenue of US$539.2 million and net income of US$50.4 million, both below prior year levels, and basic EPS dropping to US$0.73 from US$1.62. This performance puts more attention on the proposed Transocean acquisition, expected to close in Q4 2026, as a potential way to reshape Valaris's risk profile amidst weakening market conditions and overcapacity risks in the offshore drilling sector. Despite the merger, the company's investment narrative projects US$2.7 billion revenue and US$375.8 million earnings by 2029, with analysts' fair value estimates suggesting a significant downside to its current price.